China Pharma Holdings (CPHI) Exchange Rate Effect (2010 - 2026)
China Pharma Holdings' (CPHI) quarterly Exchange Rate Effect came in at $49110.0 in Q2 2026, up 223.93% on a YoY basis from $15160.7 in Q2 2025, and up 216.87% quarter-over-quarter from -$42021.0 in Q1 2026.
Powered by 
Analysis
China Pharma Holdings (CPHI) Exchange Rate Effect (2010 - 2026) Analysis & Trends
China Pharma Holdings (CPHI) has reported Exchange Rate Effect for 17 consecutive years, with $49110.0 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Exchange Rate Effect rose 223.93% year-over-year to $49110.0; the trailing twelve-month figure through Jun 2026 stood at $53337.0 (up 154.34% YoY), and the FY2025 full-year result was $1250.0, up 101.91% from the prior year.
- Exchange Rate Effect improved to $49110.0 in Q2 2026 per CPHI's latest filing, from -$42021.0 in the prior quarter.
- Across five years, Exchange Rate Effect topped out at $50439.0 in Q4 2023 and bottomed at -$153626.0 in Q3 2022.
- Historically, Exchange Rate Effect has averaged -$15150.3 across 5 years, with a median of -$757.5 in 2025.
- The widest YoY moves for Exchange Rate Effect: up 1283.72% in 2022, down 3654.3% in 2022.
- Over 5 years, Exchange Rate Effect stood at $3874.0 in 2022, then soared by 1201.99% to $50439.0 in 2023, then slumped by 225.7% to -$63400.0 in 2024, then surged by 106.08% to $3856.0 in 2025, then jumped by 1173.6% to $49110.0 in 2026.
- According to Business Quant data, Exchange Rate Effect over the past three periods registered $49110.0, -$42021.0, and $3856.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 643.26 Bn | 622.50 Bn | 17.26 Bn | 5.00 Mn |
| 2 | AbbVie | 443.31 Bn | 436.74 Bn | 12.70 Bn | -7.00 Mn |
| 3 | Merck | 364.74 Bn | 357.60 Bn | 12.21 Bn | -37.00 Mn |
| 4 | Novartis Ag | 266.46 Bn | 258.77 Bn | 11.24 Bn | -18.00 Mn |
| 5 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn | -4.00 Mn |
| 6 | Sanofi | 52.33 Bn | 44.95 Bn | 10.79 Bn | 11.62 Mn |
| 7 | Revolution Medicines | 43.79 Bn | 43.79 Bn | - | - |
| 8 | Incyte | 25.23 Bn | 20.69 Bn | 1.57 Bn | -84,000.00 |
| 9 | United Therapeutics | 21.67 Bn | 19.01 Bn | 683.80 Mn | - |
| 10 | China Pharma Holdings | 31.39 Mn | 31.08 Mn | 83,566.00 | 49,110.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 49,110.00 |
| Mar 31, 2026 | -42,021.00 |
| Dec 31, 2025 | 3,856.00 |
| Sep 30, 2025 | 42,392.00 |
| Jun 30, 2025 | -39,627.00 |
| Mar 31, 2025 | -5,371.00 |
| Dec 31, 2024 | -63,400.00 |
| Sep 30, 2024 | 10,243.00 |
| Jun 30, 2024 | -5,584.00 |
| Mar 31, 2024 | -6,655.00 |
| Dec 31, 2023 | 50,439.00 |
| Sep 30, 2023 | 4,534.00 |
| Jun 30, 2023 | -54,037.00 |
| Mar 31, 2023 | 30,989.00 |
| Dec 31, 2022 | 3,874.00 |
| Sep 30, 2022 | -153,626.00 |
| Jun 30, 2022 | -110,179.00 |
| Mar 31, 2022 | 12,358.00 |
| Dec 31, 2021 | -14,578.00 |
| Sep 30, 2021 | -4,092.00 |